HINJ 2013 Economic Impact Report

Download ‘HINJ’s 2013
Economic Impact Report’

HINJ and New Jersey's Life Sciences Community Brochure

Download HINJ and New
Jersey’s Life Sciences Community

 

 

Building-Bridges

Download the Report

HINJ AND BIONJ COMMENTARY: TO SAVE PATIENTS, KEEP NJ LIFE SCIENCES SECTOR HEALTHYCure Ahead 2

The Courier-Post has published an op-ed authored by Debbie Hart, BioNJ President and CEO, and Dean J. Paranicas, HINJ President and Chief Executive Officer.  Hart and Paranicas serve as two of the co-chairs of We Work for Health New Jersey.

“New Jersey’s representatives in Washington have long recognized the importance of fostering and protecting the innovation environment that is critical to finding the next generation of treatments and cures,” Hart and Paranicas wrote.

“We urge our policymakers to continue protecting patients and New Jersey’s economy by rejecting ill-conceived and anti-innovation proposals that could detrimentally impact our state’s economic well-being, and, more importantly, patients’ well-being here at home and around the globe,” they concluded.

To read the full op-ed, click here.

 

REP. LANCE HOSTS HINJ CEO ON ‘SEVENTH DISTRICT CONGRESSIONAL REPORT’

HINJ’s Dean Paranicas (l.) and  Congressman Leonard Lance

HINJ President and CEO Dean Paranicas was a guest on Rep. Leonard Lance’s (R-7) “Seventh District Congressional Report,” which will be broadcast on various public broadcast stations in the coming days.

Rep. Lance and Paranicas focused on the life sciences’ impact on the state’s economy; the FDA Safety Over Sequestration (SOS) Act, which seeks to exempt FDA user fees from sequestration; and the 21st Century Cures initiative.

For the full story, click here.

 

HINJ AND RX4NJ  HOSTED 2015 COMMISSIONERS FORUM ON FEBRUARY 23

HINJ and the Rx4NJ Partnership hosted the 2015 Commissioners Forum at which New Jersey’s leading healthcare policy makers discussed their departments’ care programs, 2015 plans and more. 

Participating at the Commissioners Forum will be:

  • Connie Calisti-Meyers, Assistant Commissioner, Division of HIV, STD and TB Services, Department of Health
  • Mollie Greene, Director, Clinical Services, Department of Children and Families
  • Valerie Harr, Director, Division of Medical Assistance and Health Services, Department of Human Services

 

THE VALUE OF MEDICAL INNOVATION: SAVING LIVES, SAVING MONEY

Innovation value of medical innovationHINJ President and Chief Executive Officer Dean J. Paranicas has authored an op-ed on the life sciences and the value of medical innovation.

“Medical innovations produced by American life sciences companies have vastly improved the human condition. Our pharmaceutical, biotech, medical technology, device and diagnostics companies have helped people live longer, with less pain and greater quality of life.

“Over the past century, the life sciences has eradicated some of the world’s most dreaded diseases such as polio and smallpox. More recently, the industry has made other diseases such as breast cancer, HIV/AIDS, heart disease and lung cancer no longer the death sentences that they once were.

“With these medical innovations, past and future, comes an often-overlooked benefit: the incalculable billions of dollars in savings to patients, their families, insurers, employers, governments and hospitals in avoided medical expenses associated with keeping people healthy or curing them of a life-long, chronic condition.”

To read Mr. Paranicas’ full op-ed, click here.

 

HINJ LAUNCHES ONLINE COMPENDIUM OF MEMBER COMPANIES’ CSR AND SUSTAINABILITY ACTIVITIES

CSR chasing arrowsHINJ has created an online portal to HINJ member companies’ myriad corporate social responsibility (CSR) activities, including their corporate philanthropy, patient outreach initiatives and sustainability/green practices.

The portal — “HINJ Members’ CSR Activities” — is accessible by clicking on the second tab under the HINJ homepage’s Corporate Social Responsibility menu (above) or clicking here.

For the full story, click here.

 

HINJ OP-ED: LIFE SCIENCES COMMUNITY THRIVING IN NEW JERSEY’S ‘2.0 BUSINESS ENVIRONMENT’

New Jersey sign

The Asbury Park Press has published an op-ed by HINJ President and Chief Executive Officer Dean Paranicas regarding New Jersey’s “2.0 business environment” and its impact on the state’s life sciences community.

“There have been reports that claim that New Jersey is no longer the pharmaceutical powerhouse it used to be, including a recent Asbury Park Press story by Michael L. Diamond …. We disagree. To paraphrase Mark Twain, reports of New Jersey’s demise are greatly exaggerated.

“For decades, New Jersey has rightly earned its reputation as the ‘Medicine Chest of the World’ — and our state leaders are working with the life sciences industry to keep it that way.

Mindful of the life sciences’ significant contributions to the state’s economy and global human health, Governor Christie and his economic development team, together with the State Legislature and its leadership, both Democrats and Republicans, have worked diligently over the past few years to enhance the state’s business climate to retain and grow the many life sciences companies that call New Jersey home — and attract new industry investment.

To read Mr. Paranicas’ full op-ed, click here.

 

HINJ AND NJLSVA HOST 2014 PROCUREMENT CONFERENCE AT ROWAN UNIVERSITY

Through our affiliate organization the New Jersey Life Sciences Vendors Alliance (NJLSVA), HINJ hosted its Annual Vendors Procurement Conference on October 28 at Rowan University. Forty-five vendors attended with 11 companies exhibiting.

Guest speakers included:

  • New Jersey Senate President Stephen Sweeney
  • The Honorable Rob Andrews, former Member of Congress and Of Counsel, Dilworth Paxson
  • Ken Blank, Ph.D., Senior Vice President of Health Sciences, Rowan University.

Please visit HINJ’s Facebook photo album to view photos the 2014 Procurement Conference at Rowan University.

For the complete story, click here.

RESIZE Steve Sweeney and Dean Paranicas

HINJ President and CEO Dean J. Paranicas and
NJ Senate President Stephen Sweeney

 

at life sciences celebration 2014, hinj honors rep. holt, dr. joachim kohn, students 2 science and leukemia & lymphoma society

On October 8, 2014, HINJ honored two New Jersey leaders and two organizations for their contributions in public service, life sciences research, STEM education and patient advocacy.

HINJ’s 2014 honorees were:

  • The Honorable Bob Franks Public Service Award: The Honorable Rush Holt, United States Representative, New Jersey (CD 12)
  • Research: Joachim Kohn, Ph.D., FBSE, Director, New Jersey Center for Biomaterials, Board of Governors Professor of Chemistry, Rutgers, The State University of New Jersey
  • STEM Education: Students 2 Science, Inc.
  • Patient Advocacy: Leukemia & Lymphoma Society’s New Jersey Chapter

HINJ’s guest speaker was Ethan Zohn, CBS “Survivor” winner, cancer crusher and co-founder of Grassroot Soccer.

For the complete story, click here.

ROGER CROP R94A2923 10_08_14

Front (l. to r.): Gina Murdoch, LLS-NJ; HINJ’s Dean Paranicas;
Gina Londino,
LLS-NJ.
Back (l. to r.): HINJ Chair Craig Bleifer, Daiichi Sankyo, Inc.;
Larry Fox, Dr. Paul Winslow, Don Truss, Students 2 Science;
U.S. Rep. Rush Holt; Dr. Joachim Kohn, NJ Center for Biomaterials;
“Survivor” and Cancer Crusher Ethan Zohn; Mike Shevlin, Chair, LLS-NJ.

 

HINJ’S PARANICAS APPEARS ON ‘NJ CAPITOL REPORT’ TO DISCUSS STATE’S LIFE SCIENCES SECTOR

(l. to r.) Steve Adubato, Dean Paranicas and Rafael Pi Roman.

HINJ President and Chief Executive Officer Dean J. Paranicas appears with Emmy Award-winning anchors Steve Adubato and Rafael Pi Roman on “New Jersey Capitol Report” to discuss New Jersey’s life sciences sector.

To view the half-hour episode — Paranicas begins at the 17:45-minute mark — click here.

For the complete story, click here.

 

HINJ ANNOUNCES NEW BOARD, STEERING COMMITTEE LEADERSHIP; DAIICHI SANKYO’s CRAIG BLEIFER NAMED BOARD CHAIR

Craig Bleifer

 

HINJ has announced new officers of its Board of Trustees as well as the leadership of its Steering Committee.

Craig B. Bleifer (photo), Vice President, General Counsel and Secretary, Daiichi Sankyo, Inc., has been named Chair of the HINJ Board of Trustees.

Mr. Bleifer succeeds Kevin T. Rigby, U.S. Country Head Public Affairs, Vice President Public Affairs, Novartis Pharmaceuticals Corporation.

For the complete HINJ leadership story, click here.

 

HINJ HOSTS LT. GOVERNOR GUADAGNO, CABINET MEMBERS FOR ROUNDTABLE DISCUSSION

Photo (left to right): HINJ President and CEO Dean J. Paranicas, HINJ Vice Chair Craig Bleifer (Daiichi Sankyo, Inc.), Lt. Governor Kim Guadagno and HINJ Chair Kevin Rigby (Novartis Pharmaceuticals Corporation).

On June 13, the HealthCare Institute of New Jersey (HINJ) hosted a roundtable discussion featuring New Jersey Lt. Governor Kim Guadagno on the state of the life sciences and prospects for industry growth in the Garden State as part of the HINJ Board of Trustees meeting.

Joining Lt. Governor Guadagno were State Treasurer Andrew P. Sidamon-Eristoff, Labor Commissioner Hal Wirths, New Jersey Economic Development Authority Chief Executive Officer Michele Brown and representatives from the Business Action Center and Choose New Jersey.

For additional information, click here.

 

HINJ Honors Six at Inaugural Life Sciences Celebration

The HealthCare Institute of New Jersey (HINJ) honored five New Jersey leaders and a nationally recognized high school on September 25, 2013, for their contributions in human health, public service, patient advocacy, life sciences, and science, technology, engineering and mathematics (STEM) education.

The awards were presented at HINJ’s inaugural Life Sciences Celebration, which was held at the Renaissance Woodbridge Hotel in Iselin, NJ.

Those recognized included former Governor Thomas H. Kean, the late United States Senator Frank R. Lautenberg, Dr. Christopher J. Molloy, Dr. Joseph R. Bertino, Dr. Debra L. Wentz, and Biotechnology High School.

HINJ was pleased to host three former New Jersey Governors. In addition to Governor Kean, Governor Brendan Byrne and Governor James Florio attended the event.

To read the news story, click here.

 

WELCOME TO NEW HINJ.ORG

Thank you for visiting HealthCare Institute of New Jersey (HINJ) online — and welcome to our new website!

Since our founding in 1997, HINJ has served as the voice of New Jersey’s life sciences industry, which is comprised of biopharmaceutical and medical technology companies.

Engaged in a broad range of activities throughout New Jersey, in Washington, DC and around the nation, HINJ’s work focuses on four key themes:

  • Promoting patient access to cutting-edge medicines, therapies and medical technologies
  • Bolstering an “Innovation Ecosystem” that develops advances in human health
  • Building awareness of the life sciences industry’s contributions to New Jersey’s economy
  • Helping advance corporate social responsibility, which is a hallmark of the life sciences companies

Our aim with this website is to provide information about these themes to the many who engage New Jersey’s life sciences community.

As we continue to expand our new website in the coming weeks, we hope you will find it to be a content-rich and easy-to-navigate resource. We welcome your feedback as we move forward.

Sincerely,

Dean J. Paranicas
President and Chief Executive Officer

 

Password Reset

Please enter your e-mail address. You will receive a new password via e-mail.